Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management Algorithm for Vasoplegic Shock after Cardiac Surgery: An Interdisciplinary Collaboration.

The Annals of thoracic surgery·2026
Same author

Embedding Palliative Care Clinicians in ALS Teams Improves ALS Clinicians' Confidence in Their Patient Management and Satisfaction With Palliative Care.

Muscle & nerve·2026
Same author

Outcomes of Palliative Care in Extracorporeal Life Support: A Systematic Review.

Journal of pain and symptom management·2025
Same author

Patients' and Caregivers' Perceptions of Specialty Palliative Care for Amyotrophic Lateral Sclerosis: A Multicenter Evaluation.

Muscle & nerve·2025
Same author

<i>Letter:</i> Advance Care Planning Documentation Changes Among Neurologists in an Amyotrophic Lateral Sclerosis Clinic with Addition of Specialist Palliative Care.

Journal of palliative medicine·2025
Same author

Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery.

JTCVS open·2025

Related Experiment Video

Updated: Jul 5, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

End-of-Life Care in the Cardiovascular Intensive Care Unit.

Heather Villarreal Munoz1, Orlando R Suero2, Ajith M Nair3

  • 1Department of Internal Medicine, Division of Geriatrics and Palliative Care, Baylor College of Medicine, Houston, TX, USA.

Cardiology Clinics
|July 3, 2026
PubMed
Summary

Early palliative care in the cardiovascular intensive care unit (CVICU) can improve patient quality of life. Despite benefits, it

Keywords:
Cardiovascular ICUEnd-of-life carePalliative careTransition of care

More Related Videos

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
07:49

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Jul 5, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
07:49

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment

Published on: May 10, 2022

Area of Science:

  • Cardiology
  • Palliative Care
  • Intensive Care Medicine

Background:

  • The cardiovascular intensive care unit (CVICU) cares for patients with advanced cardiac disease, often experiencing prolonged symptoms and functional decline.
  • Increasing use of advanced therapies like mechanical circulatory support leads to more deaths within the CVICU and long-term burdens for survivors.
  • Early palliative care integration in the CVICU is underutilized despite evidence of improved quality of life and reduced nonbeneficial interventions.

Purpose of the Study:

  • To explore the unique opportunities and challenges of integrating palliative care within the CVICU setting.
  • To review current advanced therapies, the role of palliative care specialists, and end-of-life practices in the CVICU.
  • To address barriers to early palliative care involvement, such as prognostic uncertainty and inconsistent referral guidelines.

Main Methods:

  • This review synthesizes existing literature on palliative care in the CVICU.
  • It examines the intersection of advanced cardiac therapies and palliative care needs.
  • The review discusses the evolving roles of palliative care teams in critical cardiac care.

Main Results:

  • A growing population of patients with advanced cardiac disease could benefit from early palliative care.
  • Palliative care can enhance quality of life and decrease nonbeneficial interventions for CVICU patients.
  • Barriers to palliative care integration include prognostic uncertainty and lack of clear referral pathways.

Conclusions:

  • Early palliative care involvement is crucial for patients in the CVICU, particularly those with advanced cardiac disease and complex needs.
  • Addressing prognostic uncertainty and establishing consistent referral guidance are essential for increasing palliative care utilization in the CVICU.
  • Optimizing palliative care in the CVICU can improve patient outcomes and support families facing end-of-life decisions.